Genomics England will use the system to help in its clinical reporting for the 100,000 Genome Project's cancer program.
Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.
The partnership is part of a broader agreement between Genome BC and Genomics England to share data and tools around cancer and rare and infectious diseases.
The companies are planning to build a platform and database that can be used to improve and automate the interpretation of genomic data.
Icon will use its data management capabilities and clinical trials expertise to validate clinical data from the 70,000 participating patients and their families.
Genomics England has selected WuXi Nextcode to interpret genomic data from cancer and rare disease samples as part of the UK 100K Genomes Project.
Genomics England will use LabKey's server solution to integrate and share clinical and genomic data as part of the project
Congenica and Omicia have signed contracts to interpret data from the first 8,000 patients in the UK's 100,000 Genomes Project.
Congenica will use the grant to extend the functionality of Sapientia, its software for analyzing and interpreting whole-genome data.
Under the agreement, the organizations will work on making genomic information more accessible, meaningful, and usable.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.